Hepatocellular Cancer Video Channel

Explore the latest insights and summaries from experts in Hepatocellular Cancer.

Therapeutic Agents

07:52

Cedars Sinai

Management of Toxicity and Dose Modification Associated With Cabozantinib in HCC

FEATURING Jun Gong
  • 265 views
  • April 19, 2024
  • 1
09:41

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "HCC Highlights From the CheckMate 9DW and CARES-310 Studies"

FEATURING Arndt Vogel
  • 221 views
  • June 25, 2024
  • 2
08:08

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Atezo + Bev as 1L Systemic Therapy for aHCC - Outcomes Based on Child Pugh and ALBI Liver Function"

FEATURING Michael Storandt
  • 87 views
  • July 1, 2024
07:20

Insights from 2024 ESMO GI Annual Meeting

ESMO GI 2024 Insights: 1L Unresectable HCC - Outcomes by Comorbidities With STRIDE (Durvalumab & Tremelimumab Regimen) in the HIMALAYA Study

FEATURING Lorenza Rimassa
  • 146 views
  • July 5, 2024
04:17

Nebraska Oncology Society

Recent Updates in the Treatment Landscape for Advanced HCC

FEATURING Rachael Safyan
  • 51 views
  • August 13, 2024
21:24

Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression from Child-Pugh A to Child-Pugh B Liver Function

FEATURING Julio Gutierrez, Joshua Strauss
  • 119 views
  • November 11, 2024
13:36

Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Considerations for 2L Treatment Post Sorafenib

FEATURING Julio Gutierrez, Joshua Strauss
  • 77 views
  • November 11, 2024
09:56

2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: HIMALAYA - 5-Year OS of Tremelimumab + Durvalumab in Unresectable HCC

FEATURING Lorenza Rimassa
  • 173 views
  • September 20, 2024
04:39

2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: TACE ± Lenvatinib + Pembro for Int-Stage HCC - Ph3 LEAP-012 Study

FEATURING Josep Llovet
  • 210 views
  • September 23, 2024
  • 3
25:57

Houston Methodist

Management of Hepatocellular Carcinoma & Cholangiocarcinoma - Role of Immunotherapy & Ablative Therapies

FEATURING Ahmed O. Kaseb
  • 43 views
  • October 3, 2024
05:40

2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: CheckMate 9DW Expanded Analysis - Nivo + Ipi vs. Len or Sorafenib in 1L Unresectable HCC

FEATURING Hatim Karachiwala
  • 137 views
  • October 21, 2024
  • 2
10:57

UCLA Health

Y90 Radioembolization for Locally Advanced HCC

FEATURING Siddharth Padia
  • 650 views
  • March 1, 2024
  • 4
16:10

Malkhaz Mizandari

HCC Percutaneous Radio-Ablation Using BAT-90: Results of an Ongoing First-in-Human Clinical Trial

  • 265 views
  • March 1, 2024
04:37

Florida Gastroenterologic Society

Hepatology Q&A

FEATURING Roberto Firpi-Morell, Anjuli Luthra, Sunil Amin
  • 8 views
  • September 12, 2024
16:44

Keck School of Medicine of USC

Hepatology Q&A/Panel Discussion

FEATURING Hyosun Helen Han, Mitra Nadim, Kali Zhou, Saroja Bangaru, Mary E. Rinella
  • 19 views
  • September 25, 2024
12:43

Houston Methodist

Liver Cancers: Hepatocellular Carcinoma & Cholangiocarcinoma - Current Concepts & Controversies Q&A and Discussion

FEATURING Ashton Connor, Ahmed O. Kaseb, Sudha Kodali
  • 13 views
  • October 3, 2024
07:41

Johns Hopkins

Impact of Neoadjuvant IO on Recurrence-Free Survival in High-Risk Localized HCC

FEATURING Mari Nakazawa
  • 97 views
  • November 7, 2024